Company Overview of Reckitt Benckiser (India) Ltd
Reckitt Benckiser (India) Ltd is engaged in the manufacture, sale and export of drugs and medicines, such as bulk drugs in the form of liquids, ointments, and tablets; denture products; food products, including tea, cashew kernels, and mushrooms; laundry products; household products; aromatic chemicals; and toiletries. The company was incorporated in 1951 and is based in Gurgaon, India. Reckitt Benckiser (India) Ltd operates as a subsidiary of Reckitt Benckiser Group plc.
Enkay Centre 2nd Floor
Vanijya Nikunj Udyog Vihar
Gurgaon, 122 016
Founded in 1951
91 12 4402 8100
91 12 4239 8231
Key Executives for Reckitt Benckiser (India) Ltd
Chairman and Member of Audit Committee
Compensation as of Fiscal Year 2014.
Reckitt Benckiser (India) Ltd Key Developments
Reckitt Benckiser Announces the Availability of MegaRed in Canada, a New Krill Oil Supplement
Feb 5 14
Reckitt Benckiser announced the availability of MegaRed in Canada, a new 100% krill oil supplement that offers Canadians the essential omega-3 fatty acids to help maintain a healthy lifestyle. MegaRed is one of the best sources of omega-3 fatty acids available to Canadians and contains oil from pure Antarctic krill, tiny crustaceans that thrive in the frigid waters of the Antarctic. Omega-3 is a form of health-promoting polyunsaturated fat that is essential for the human body and helps to promote vascular, heart and cognitive health. Cold water seafood like salmon, mackerel, herring and krill are among the best sources of omega-3 fatty acids, in addition to some plants and oils like flax seed. There are different types of omega-3 fatty acids and it helps to get the right omega-3 fat combination to optimize the health benefits. Some people find that traditional fish oil supplements may cause indigestion, unpleasant odour and aftertaste. Krill oil is absorbed more readily by the body because much of the omega-3 fatty acids are bound to phospholipids (not triglycerides), and dissolves in the stomach allowing for the body to more quickly absorb the omega-3 without any unpleasant odour or aftertaste.
Reckitt Benckiser India Plans To Buy 26% Stake in Paras
Jan 23 14
Reckitt Benckiser (India) Ltd plans to buy around 26% stake in Paras Pharmaceuticals Limited from Reckitt Benckiser Group plc (LSE:RB.) for INR 7.25 billion as part of a move to make the healthcare firm its wholly- owned subsidiary in the long run. "The company has adequate internal accruals to meet the proposal for the said investment," it said. According to Economic Times, an email sent to RB India's spokeswoman elicited no response till late on January 22, 2014.
Reckitt Benckiser (India) Ltd Announces Management Changes
Nov 28 13
Reckitt Benckiser India will have new managing director in January when Nitish Kapoor, the UK multinational’s global category director for pest control, replaces Akhil Chandra at the helm. Chandra will relocate to the company headquarters in Slough, Berkshire, as a category director, two persons with direct knowledge of the development told ET. Chandra, who quit as VP and GM – Asia at Glaxo SmithKline Consumer Healthcare, Malaysia, last year to join Reckitt Benckiser, is moving out of the top job in India in just over a year. His predecessor S Raghunandan had quit within just three weeks of taking up the job early last year.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|